Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001320482 | SCV001511271 | uncertain significance | Alagille syndrome due to a JAG1 point mutation | 2022-05-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1020832). This variant has not been reported in the literature in individuals affected with JAG1-related conditions. This variant is present in population databases (rs771530161, gnomAD 0.0009%). This variant, c.3287_3295del, results in the deletion of 3 amino acid(s) of the JAG1 protein (p.Arg1096_Lys1098del), but otherwise preserves the integrity of the reading frame. |
Fulgent Genetics, |
RCV002486275 | SCV002788987 | uncertain significance | Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH | 2022-04-14 | criteria provided, single submitter | clinical testing |